BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coluzzi F, Rolke R, Mercadante S. Pain Management in Patients with Multiple Myeloma: An Update. Cancers (Basel) 2019;11:E2037. [PMID: 31861097 DOI: 10.3390/cancers11122037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Bernstein ZS, Kim EB, Raje N. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells 2022;11:2308. [DOI: 10.3390/cells11152308] [Reference Citation Analysis]
2 Saltarella I, Altamura C, Lamanuzzi A, Apollonio B, Vacca A, Frassanito MA, Desaphy J. Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives. IJMS 2022;23:7302. [DOI: 10.3390/ijms23137302] [Reference Citation Analysis]
3 Quinn B, Laurent S, Dargan S, Lapuente M, Lüftner D, Drudge-Coates L, Palma MD, Lago LD, Flynn J, Panter C, Seesaghur A. Managing Advanced Cancer Pain Together (MACPT) conversation tool: an evaluation of use in clinical practice. Pain Manag 2021. [PMID: 34866400 DOI: 10.2217/pmt-2021-0066] [Reference Citation Analysis]
4 Pallotti MC, Rossi R, Scarpi E, Dall'Agata M, Ricci M, Ceccolini M, Ronconi S, Valenti V, Maltoni M, Martinelli G, Cerchione C. Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes. Support Care Cancer 2021. [PMID: 34718886 DOI: 10.1007/s00520-021-06560-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lim VM, Barney T, Jayaraman AL. Multiple myeloma and malignant lesions: a potential risk factor for local anesthetic systemic toxicity. Reg Anesth Pain Med 2021;46:1103-6. [PMID: 34535547 DOI: 10.1136/rapm-2021-102845] [Reference Citation Analysis]
6 Stamm SL, Spichiger E, Pabst T, Bachnick S, Jeitziner MM. Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - A longitudinal observational study. Eur J Oncol Nurs 2021;53:101997. [PMID: 34294574 DOI: 10.1016/j.ejon.2021.101997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Quinn B, Ludwig H, Bailey A, Khela K, Marongiu A, Carlson KB, Rider A, Seesaghur A. Physical, emotional and social pain communication by patients diagnosed and living with multiple myeloma. Pain Manag 2021. [PMID: 34139887 DOI: 10.2217/pmt-2021-0013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ludwig H, Bailey AL, Marongiu A, Khela K, Milligan G, Carlson KB, Rider A, Seesaghur A. Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice. Cancer Rep (Hoboken) 2021;:e1429. [PMID: 34110106 DOI: 10.1002/cnr2.1429] [Reference Citation Analysis]
9 Selvy M, Kerckhove N, Pereira B, Barreau F, Nguyen D, Busserolles J, Giraudet F, Cabrespine A, Chaleteix C, Soubrier M, Bay JO, Lemal R, Balayssac D. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Front Pharmacol 2021;12:637593. [PMID: 33967771 DOI: 10.3389/fphar.2021.637593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kaweme NM, Changwe GJ, Zhou F. Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects. Front Med (Lausanne) 2021;8:612696. [PMID: 33718400 DOI: 10.3389/fmed.2021.612696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yamamoto S, Egashira N. Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy. Int J Mol Sci 2021;22:E888. [PMID: 33477371 DOI: 10.3390/ijms22020888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
12 Celin MR, Simon JC, Krzak JJ, Fial AV, Kruger KM, Smith PA, Harris GF. Do Bisphosphonates Alleviate Pain in Children? A Systematic Review. Curr Osteoporos Rep 2020;18:486-504. [PMID: 32960409 DOI: 10.1007/s11914-020-00621-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Coluzzi F, Mercadante S. The Potential Role of Dual Mechanistic Opioids in Combating Opioid Misuse. Curr Anesthesiol Rep 2020;10:416-22. [DOI: 10.1007/s40140-020-00414-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Imai Y. Latest Development in Multiple Myeloma. Cancers (Basel) 2020;12:E2544. [PMID: 32906677 DOI: 10.3390/cancers12092544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]